64 results
8-K
EX-10.2
KPRX
Kiora Pharmaceuticals Inc
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
or the creditors of the Company or any other person by virtue of this Agreement or the retention of such Placement Agent hereunder, all of which are hereby
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
to the Indemnitor to, and reasonable retention by the Indemnitee of, records and information that are reasonably relevant to such Third Party Claim, and making
8-K
EX-99.1
aw3 zssgspq83rjal
11 Jan 22
Regulation FD Disclosure
12:00am
8-K
EX-2.1
1f9wun8
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-99.1
7x73fc0
14 Sep 21
Regulation FD Disclosure
4:20pm
424B5
j4sepstq12g
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-10.2
c0mukl2ybld
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-99.1
2a4t3knpm
27 May 21
Regulation FD Disclosure
7:01am